Pipeline Trends features concise, impartial data on drugs in development and their potential place in therapy. This June 2012 issue includes updates on buprenorphine, cariprazine, daclatasvir, tedizolid, and other new drugs.

The information in Pipeline Trends, a biannual publication, helps subscribers plan for future initiatives.